Business Description
Codexis Inc
NAICS : 541714
SIC : 8731
ISIN : US1920051067
Total Employee Number:
146Description
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.89 | |||||
Equity-to-Asset | 0.33 | |||||
Debt-to-Equity | 1.69 | |||||
Debt-to-EBITDA | -3.58 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -4.72 | |||||
Beneish M-Score | -3.02 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -27.5 | |||||
3-Year EBITDA Growth Rate | 1.2 | |||||
3-Year EPS without NRI Growth Rate | 0.2 | |||||
3-Year Book Growth Rate | -36.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 19.02 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 15.03 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 41.41 | |||||
9-Day RSI | 41.56 | |||||
14-Day RSI | 43.09 | |||||
3-1 Month Momentum % | -4.62 | |||||
6-1 Month Momentum % | 48.5 | |||||
12-1 Month Momentum % | -13.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.36 | |||||
Quick Ratio | 5.23 | |||||
Cash Ratio | 4.39 | |||||
Days Inventory | 79.81 | |||||
Days Sales Outstanding | 37.65 | |||||
Days Payable | 114.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.2 | |||||
Shareholder Yield % | -9.84 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 88.9 | |||||
Operating Margin % | -33.15 | |||||
Net Margin % | -40.97 | |||||
EBITDA Margin % | -26.09 | |||||
FCF Margin % | -28.33 | |||||
OCF Margin % | -23.98 | |||||
ROE % | -67.33 | |||||
ROA % | -23.94 | |||||
ROIC % | -40.46 | |||||
3-Year ROIIC % | 14.37 | |||||
ROC (Joel Greenblatt) % | -60.83 | |||||
ROCE % | -23.33 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2.56 | |||||
PB Ratio | 4.7 | |||||
Price-to-Tangible-Book | 4.97 | |||||
EV-to-EBIT | -7.88 | |||||
EV-to-EBITDA | -10.35 | |||||
EV-to-Revenue | 2.7 | |||||
EV-to-Forward-Revenue | 0.59 | |||||
EV-to-FCF | -9.54 | |||||
Price-to-GF-Value | 0.87 | |||||
Price-to-Median-PS-Value | 0.49 | |||||
Earnings Yield (Greenblatt) % | -12.69 | |||||
FCF Yield % | -10.89 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CDXS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Codexis Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 78.092 | ||
| EPS (TTM) ($) | -0.37 | ||
| Beta | 3.5942 | ||
| 3-Year Sharpe Ratio | 0.31 | ||
| 3-Year Sortino Ratio | 0.61 | ||
| Volatility % | 110.66 | ||
| 14-Day RSI | 43.09 | ||
| 14-Day ATR ($) | 0.165309 | ||
| 20-Day SMA ($) | 2.37625 | ||
| 12-1 Month Momentum % | -13.89 | ||
| 52-Week Range ($) | 0.9583 - 3.87 | ||
| Shares Outstanding (Mil) | 90.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Codexis Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Codexis Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 16:30 | In 110 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 109 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-13 16:30 | In 25 days | ||
| Second quarter earnings results for 2026 | 2026-08-13 | In 24 days | ||
| General meeting for 2026 | 2026-06-10 09:00 | 2.47 (-5.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 16:30 | 2.66 (-4.32%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 2.66 (-4.32%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-11 16:30 | 1.24 (-2.36%) | ||
| Annual report for 2025 | 2026-03-11 | 1.24 (-2.36%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-11 | 1.24 (-2.36%) |
Show
Entries
Codexis Inc Frequently Asked Questions
What is Codexis Inc(CDXS)'s stock price today?
The current price of CDXS is $2.24. The 52 week high of CDXS is $3.87 and 52 week low is $0.96.
When is next earnings date of Codexis Inc(CDXS)?
The next earnings date of Codexis Inc(CDXS) is 2026-08-13 Est..
Does Codexis Inc(CDXS) pay dividends? If so, how much?
Codexis Inc(CDXS) does not pay dividend.
Guru Commentaries on NAS:CDXS
No articles.
Press Release
Articles on Codexis Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers